.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
The ASPRE trial tested nightly low-dose aspirin in women identified by first-trimester screening as being at high risk of preterm preeclampsia. Aspirin started early in pregnancy reduced the incidence of preterm preeclampsia compared with placebo. The study is important because it demonstrates the value of combining risk prediction with an inexpensive preventive intervention. For clinicians, the key challenge is identifying the appropriate high-risk population and initiating aspirin at the correct gestational window rather than using it indiscriminately. The trial also highlights how first-trimester maternal characteristics and biophysical or biochemical markers can support risk stratification. Aspirin is not a substitute for surveillance, management of chronic hypertension or treatment of established preeclampsia. Its role is preventive, and adherence matters. The study is particularly relevant to high-risk obstetric pathways that aim to move from reactive treatment of severe disease toward earlier prevention.
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
The ASPRE trial tested nightly low-dose aspirin in women identified by first-trimester screening as being at high risk of preterm preeclampsia. Aspirin started early in pregnancy reduced the incidence of preterm preeclampsia compared with placebo. The study is important because it demonstrates the value of combining risk prediction with an inexpensive preventive intervention. For clinicians, the key challenge is identifying the appropriate high-risk population and initiating aspirin at the correct gestational window rather than using it indiscriminately. The trial also highlights how first-trimester maternal characteristics and biophysical or biochemical markers can support risk stratification. Aspirin is not a substitute for surveillance, management of chronic hypertension or treatment of established preeclampsia. Its role is preventive, and adherence matters. The study is particularly relevant to high-risk obstetric pathways that aim to move from reactive treatment of severe disease toward earlier prevention.
Today
The phase 3 ACACIA-HCM trial reveals that aficamten improves cardiac structure, diastolic relaxation, functional capacity, and symptom burden in symptomatic nonobstructive hypertrophic cardiomyopathy, marking a major milestone in targeted myosin inhibition.
6 days back
A clinical study shows that automated breast ultrasound paired with artificial intelligence accurately classifies BIRADS 3-4 lesions, reaching 95% sensitivity and 79% specificity. This diagnostic advance promises to reduce unnecessary core needle biopsies and refine clinical workflows in breast imaging.
3 weeks back
Researchers have engineered freestanding hierarchical-porous BCZT thin films that resist cracking and enhance ultrasonic energy harvesting in soft tissue. Achieving high piezoelectric output and acoustic matching, this lead-free material offers transformative potential for implantable bioelectronics.
Last week
A novel pathology-adaptive surface engineering strategy uses functionalized plasma polymer coatings to selectively modulate AGE adsorption, reducing oxidative stress and restoring bone formation in diabetic and aging microenvironments.
3 weeks back
A breakthrough study identifies the Klotho/PKCα/CUX1/SPARC/TGFβ-RII axis as a critical driver of podocyte mitochondrial injury and ferroptosis in diabetic kidney disease, unveiling promising molecular targets to halt renal disease progression.
6 days back
